New Research Benchmarks Pharma’s Changing Utilization of Real-World

Evidence (RWE) and Its Impact on Contract Research Organizations (CROs)

Study Tracks Utilization of Real-World Data (RWD), Real-World Evidence (RWE) and Supportive
Services and Implications to CROs.

Menlo Park, CA, June 11, 2019 --(PR.com)-- Life Science Strategy Group (LSSG), a leading strategic
consulting firm to the CRO industry, is pleased to announce the availability of its 2019 syndicated report
on Real-World Evidence - "A Market at an Inflection Point and its Impact on the CRO Industry." This
benchmark study provides a detailed look into the pharmaceutical industry's utilization of real-world
evidence (RWE), the changing RWD/RWE landscape within biopharmaceutical companies and its
implications on CRO business models and strategies.

Life Science Strategy Group's new report provides insights from 100 professionals from small, medium,
and large global biopharmaceutical companies into the current attitudes towards RWE, its role in the
product lifecycle, the current state of RWE-based strategy implementation and outsourcing and
perceptions of leading CRO providers including IQVIA, Covance, Parexel, PPD and ICON. Further, the
report discusses the implications of the biopharmaceutical industry's adoption of RWE-based approaches
on traditional CROs.

The report provides data on RWE trends, use and study design, barriers to RWE use to support product
development, RWD/RWE buying processes, vendor selection criteria, and RWE outsourcing. According
to Jon Meyer, Principal, Life Science Strategy Group, “Biopharmaceutical companies are increasing their
investment in real-world data, analytics and evidence with mixed results. Traditional CROs are working
actively to augment internal capabilities with RWE-based services. However, given the challenges
involved and 'one-off' nature of real-world evidence generation, the CRO industry is at a crossroads.”

To learn more about the rapidly changing RWE marketplace and its impact on CROs, or to download
sample pages from the report, visit
http://lifesciencestrategy.com/publications/cro-industry/pubs-cro-real-world-june-2019/

About Life Science Strategy Group, LLC

Life Science Strategy Group, LLC is a consultancy specializing in strategic consulting, market research
engagements and syndicated publications across a variety of therapeutic, technology and service
industries including contract research services, pharmaceutical, biotechnology, medical devices,
diagnostics and drug discovery.

Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
Life Science Strategy Group, LLC
Jon Meyer
1-800-941-6373
Contact via Email
www.lifesciencestrategy.com

Online Version of Press Release:

You can read the online version of this press release at: https://www.pr.com/press-release/787049

Page 2/2
PR.com Press Release Distribution Terms of Use